NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

369.20 0.80 (0.22%)

26.87% Gain from 52W Low

14.4M NSE+BSE Volume

High volume today

NSE 19 Sep, 2025 3:31 PM (IST)

49,360.7

Market Cap

Market Leader

1.2

Beta 1Year

Very High Volatility

US FDA Approval

Biocon's arm gets US FDA approval for Bosaya and Aukelso injections with a market size of $5 bn See details

Biocon Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BIOCON, BSE:532523 Biocon Ltd.

Is Biocon Ltd. worth buying?

727 Votes:

Buy 74.97%

Sell 16.37%

Hold 8.67%

RESEARCH REPORTS

Buy SEE REPORTS >

Sell SEE REPORTS >